Drug Shortage Report for LUPIN-CEPHALEXIN
Report ID | 104528 |
Drug Identification Number | 02469170 |
Brand name | LUPIN-CEPHALEXIN |
Common or Proper name | LUPIN-CEPHALEXIN |
Company Name | LUPIN PHARMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CEPHALEXIN |
Strength(s) | 125MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 100 ML and 150 ML |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-28 |
Estimated end date | 2020-10-09 |
Actual end date | 2020-10-05 |
Shortage status | Resolved |
Updated date | 2020-10-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 550-1111 RUE ST-CHARLES OUEST LONGUEUIL, QUEBEC CANADA J4K 5G4 |
Company contact information | lupin@lsu3pl.ca (Customer service / Service à la clientèle) |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v23 | 2020-10-06 | English | Compare |
v22 | 2020-10-05 | French | Compare |
v21 | 2020-10-05 | English | Compare |
v20 | 2020-09-30 | French | Compare |
v19 | 2020-09-30 | English | Compare |
v18 | 2020-08-27 | French | Compare |
v17 | 2020-08-27 | English | Compare |
v16 | 2020-07-25 | French | Compare |
v15 | 2020-07-25 | English | Compare |
v14 | 2020-07-07 | French | Compare |
v13 | 2020-07-07 | English | Compare |
v12 | 2020-07-07 | English | Compare |
v11 | 2020-01-29 | English | Compare |
v10 | 2020-01-28 | French | Compare |
v9 | 2020-01-28 | English | Compare |
v8 | 2020-01-28 | English | Compare |
v7 | 2020-01-28 | English | Compare |
v6 | 2020-01-28 | English | Compare |
v5 | 2020-01-28 | English | Compare |
v4 | 2020-01-28 | French | Compare |